Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

NCT01873729 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01873729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01873729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2013
Completion date
June 30, 2016
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder